Grindrod Shipping Competitors

Grindrod Shipping (CNSX:GRIN) and RIV Capital (TSE:RIV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of recent ratings for Grindrod Shipping and RIV Capital, as provided by MarketBeat.

Grindrod Shipping currently has a consensus target price of $0.73, indicating a potential upside of ∞. RIV Capital has a consensus target price of C$4.00, indicating a potential upside of 90.48%. Given Grindrod Shipping's stronger consensus rating and higher possible upside, research analysts clearly believe Grindrod Shipping is more favorable than RIV Capital.

Earnings & Valuation

This table compares Grindrod Shipping and RIV Capital's top-line revenue, earnings per share and valuation.

Grindrod Shipping has higher earnings, but lower revenue than RIV Capital.

Profitability

This table compares Grindrod Shipping and RIV Capital's net margins, return on equity and return on assets.

Summary

Grindrod Shipping beats RIV Capital on 3 of the 4 factors compared between the two stocks.

Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Willow Biosciences Inc. (WLLW.TO) and Grindrod Shipping, as reported by MarketBeat.com.

Willow Biosciences Inc. (WLLW.TO) currently has a consensus target price of C$2.25, indicating a potential upside of 74.42%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than Willow Biosciences Inc. (WLLW.TO).

Valuation and Earnings

This table compares Willow Biosciences Inc. (WLLW.TO) and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Grindrod Shipping has lower revenue, but higher earnings than Willow Biosciences Inc. (WLLW.TO).

Profitability

This table compares Willow Biosciences Inc. (WLLW.TO) and Grindrod Shipping's net margins, return on equity and return on assets.

Summary

Grindrod Shipping beats Willow Biosciences Inc. (WLLW.TO) on 2 of the 3 factors compared between the two stocks.

MediPharm Labs (TSE:LABS) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for MediPharm Labs and Grindrod Shipping, as reported by MarketBeat.com.

MediPharm Labs currently has a consensus target price of C$1.53, indicating a potential upside of 218.75%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than MediPharm Labs.

Valuation and Earnings

This table compares MediPharm Labs and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Grindrod Shipping has lower revenue, but higher earnings than MediPharm Labs.

Profitability

This table compares MediPharm Labs and Grindrod Shipping's net margins, return on equity and return on assets.

Khiron Life Sciences (CVE:KHRN) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Khiron Life Sciences and Grindrod Shipping, as reported by MarketBeat.com.

Khiron Life Sciences currently has a consensus target price of C$1.20, indicating a potential upside of 122.22%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than Khiron Life Sciences.

Valuation and Earnings

This table compares Khiron Life Sciences and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Grindrod Shipping has lower revenue, but higher earnings than Khiron Life Sciences.

Profitability

This table compares Khiron Life Sciences and Grindrod Shipping's net margins, return on equity and return on assets.

Summary

Grindrod Shipping beats Khiron Life Sciences on 2 of the 3 factors compared between the two stocks.

Delta 9 Cannabis (TSE:DN) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Valuation and Earnings

This table compares Delta 9 Cannabis and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Grindrod Shipping has lower revenue, but higher earnings than Delta 9 Cannabis.

Analyst Recommendations

This is a summary of recent ratings and target prices for Delta 9 Cannabis and Grindrod Shipping, as reported by MarketBeat.com.

Delta 9 Cannabis currently has a consensus target price of C$1.24, indicating a potential upside of 113.79%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than Delta 9 Cannabis.

Profitability

This table compares Delta 9 Cannabis and Grindrod Shipping's net margins, return on equity and return on assets.

Summary

Delta 9 Cannabis beats Grindrod Shipping on 3 of the 5 factors compared between the two stocks.

Grindrod Shipping (CNSX:GRIN) and Meta Growth (CVE:META) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Grindrod Shipping and Meta Growth's gross revenue, earnings per share (EPS) and valuation.

Grindrod Shipping has higher earnings, but lower revenue than Meta Growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Grindrod Shipping and Meta Growth, as reported by MarketBeat.

Grindrod Shipping presently has a consensus price target of $0.73, suggesting a potential upside of ∞. Given Grindrod Shipping's higher probable upside, research analysts plainly believe Grindrod Shipping is more favorable than Meta Growth.

Profitability

This table compares Grindrod Shipping and Meta Growth's net margins, return on equity and return on assets.

Summary

Grindrod Shipping beats Meta Growth on 2 of the 3 factors compared between the two stocks.